Nanofibrous PCL-Based Human Trabecular Meshwork for Aqueous Humor Outflow Studies.
drug screening
electrospinning
glaucoma
outflow system
polycaprolactone
trabecular meshwork
Journal
ACS biomaterials science & engineering
ISSN: 2373-9878
Titre abrégé: ACS Biomater Sci Eng
Pays: United States
ID NLM: 101654670
Informations de publication
Date de publication:
13 11 2023
13 11 2023
Historique:
medline:
14
11
2023
pubmed:
19
9
2023
entrez:
19
9
2023
Statut:
ppublish
Résumé
Primary open-angle glaucoma is characterized by the progressive degeneration of the optic nerve, with the high intraocular pressure (IOP) being one of the main risk factors. The human trabecular meshwork (HTM), specifically the juxtacanalicular tissue (JCT), is responsible for placing resistance to the aqueous humor (AH) outflow and the resulting IOP control. Currently, the lack of a proper
Identifiants
pubmed: 37725561
doi: 10.1021/acsbiomaterials.3c01071
pmc: PMC10646841
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6333-6344Références
Biotechnol Bioeng. 2020 Oct;117(10):3150-3159
pubmed: 32589791
ACS Biomater Sci Eng. 2022 Sep 12;8(9):3899-3911
pubmed: 35984428
Sci Rep. 2016 Dec 07;6:38319
pubmed: 27924833
Biotechnol Bioeng. 2013 Dec;110(12):3205-18
pubmed: 23775275
Exp Eye Res. 2009 Apr;88(4):676-82
pubmed: 19087875
Am J Physiol. 1999 Aug;277(2):C330-42
pubmed: 10444410
Biotechnol Bioeng. 2016 Jun;113(6):1357-68
pubmed: 26615056
Invest Ophthalmol Vis Sci. 2016 Nov 01;57(14):6197-6209
pubmed: 27842161
Invest Ophthalmol Vis Sci. 1990 Dec;31(12):2568-71
pubmed: 2125032
Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1566-75
pubmed: 22297497
J Clin Med. 2020 Oct 31;9(11):
pubmed: 33142742
Acta Biomater. 2019 Dec;100:244-254
pubmed: 31557533
Bioengineering (Basel). 2023 Jun 02;10(6):
pubmed: 37370610
J Fr Ophtalmol. 2020 Sep;43(7):e217-e230
pubmed: 32561029
Exp Eye Res. 1991 Jun;52(6):723-31
pubmed: 1855546
Prog Retin Eye Res. 2002 Jul;21(4):395-428
pubmed: 12150989
Nat Rev Dis Primers. 2016 Sep 22;2:16067
pubmed: 27654570
Toxicol In Vitro. 2017 Jun;41:21-29
pubmed: 28214551
Biotechnol Bioeng. 2017 Apr;114(4):915-923
pubmed: 27775151
Cell Motil Cytoskeleton. 2005 Feb;60(2):83-95
pubmed: 15593281
Materials (Basel). 2020 May 06;13(9):
pubmed: 32384813
Invest Ophthalmol Vis Sci. 1994 Jan;35(1):281-94
pubmed: 8300356
Invest Ophthalmol Vis Sci. 1982 Oct;23(4):464-78
pubmed: 7118506
Invest Ophthalmol Vis Sci. 2011 Apr 05;52(5):2147-52
pubmed: 21220561
Biomaterials. 2008 Jul;29(19):2899-906
pubmed: 18400295
Sci Rep. 2018 Oct 19;8(1):15472
pubmed: 30341380
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4181-7
pubmed: 17003404
Biomaterials. 2015 Oct;65:86-92
pubmed: 26142779
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Exp Eye Res. 2021 Apr;205:108472
pubmed: 33516765
Front Neurol. 2020 Dec 01;11:591776
pubmed: 33335510
Arch Ophthalmol. 1963 Jun;69:783-801
pubmed: 13949877
J Ocul Pharmacol Ther. 2018 Jun;34(5):380-386
pubmed: 29469601
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):262-9
pubmed: 18172101
Invest Ophthalmol Vis Sci. 1995 Feb;36(2):478-89
pubmed: 7843916
Exp Eye Res. 2013 Aug;113:66-73
pubmed: 23727052
Exp Eye Res. 2009 Apr;88(4):648-55
pubmed: 19239914
Biotechnol Bioeng. 2022 Oct;119(10):2698-2714
pubmed: 35836364
Biomaterials. 2012 Sep;33(26):6020-41
pubmed: 22681979
Curr Opin Ophthalmol. 2012 Mar;23(2):135-43
pubmed: 22262082
Cell Tissue Res. 2012 Jan;347(1):279-90
pubmed: 22101332
Open Ophthalmol J. 2010 Sep 03;4:52-9
pubmed: 21293732
Invest Ophthalmol Vis Sci. 2001 Apr;42(5):1029-37
pubmed: 11274082